OLD National Bancorp IN Has $19.20 Million Stock Position in Danaher Corporation $DHR

OLD National Bancorp IN boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 14.3% during the fourth quarter, Holdings Channel reports. The fund owned 83,854 shares of the conglomerate’s stock after acquiring an additional 10,467 shares during the period. OLD National Bancorp IN’s holdings in Danaher were worth $19,196,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Capital International Investors grew its stake in shares of Danaher by 1.9% during the third quarter. Capital International Investors now owns 16,758,240 shares of the conglomerate’s stock valued at $3,318,926,000 after purchasing an additional 312,951 shares during the last quarter. Generation Investment Management LLP raised its position in Danaher by 34.0% in the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after purchasing an additional 1,689,020 shares during the last quarter. Legal & General Group Plc raised its position in Danaher by 5.0% in the 3rd quarter. Legal & General Group Plc now owns 4,452,118 shares of the conglomerate’s stock worth $882,677,000 after purchasing an additional 211,053 shares during the last quarter. Fisher Asset Management LLC lifted its holdings in Danaher by 0.7% during the 3rd quarter. Fisher Asset Management LLC now owns 4,369,219 shares of the conglomerate’s stock worth $866,241,000 after buying an additional 28,583 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its position in Danaher by 104.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock valued at $991,923,000 after buying an additional 2,216,789 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 3.4%

Shares of NYSE DHR opened at $177.71 on Thursday. The stock has a market cap of $125.77 billion, a P/E ratio of 34.44, a P/E/G ratio of 2.64 and a beta of 0.95. The firm has a 50 day moving average price of $197.17 and a 200 day moving average price of $214.35. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. Danaher Corporation has a 52-week low of $180.03 and a 52-week high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, April 21st. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.96%. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period last year, the business posted $1.88 earnings per share. Danaher has set its FY 2026 guidance at 8.350-8.550 EPS. Analysts expect that Danaher Corporation will post 8.39 EPS for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, March 27th. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio (DPR) is 30.95%.

Insiders Place Their Bets

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 10.80% of the company’s stock.

More Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Q1 EPS beat and slight full‑year EPS raise: Danaher reported $2.06 non‑GAAP EPS (ahead of estimates) and nudged FY‑2026 adjusted EPS guidance to a range that was only modestly higher, supporting the view of durable profitability. Read More.
• Positive Sentiment: Analyst support from Evercore: Evercore raised its price target (to $232) and maintained an outperform stance, providing some buy‑side reinforcement amid the downdraft. Read More.
• Neutral Sentiment: Large euro‑note offering announced: Danaher priced ~€3.0B net of proceeds in four tranches (2028–2038 maturities). The deal boosts liquidity but increases gross debt on the balance sheet while funding corporate needs (including M&A). Read More.
• Neutral Sentiment: Bioprocessing strength vs. mixed start: Management highlighted bioprocessing momentum and acquisition strategy, which helped headline growth, but the quarter showed mixed signals across segments. Read More.
• Negative Sentiment: Revenue miss and Diagnostics softness: Revenue rose ~3.7% Y/Y but missed consensus; core revenue growth was modest and Diagnostics saw weakness (lighter respiratory season at Cepheid), which worried investors despite the EPS beat. Read More.
• Negative Sentiment: Multiple price‑target cuts: Several firms trimmed targets (JPMorgan, UBS, Guggenheim, Wells Fargo, TD Cowen among others), which can prompt headline selling and reduce near‑term upside expectations. Read More. Read More. Read More.
• Negative Sentiment: Market concern about Masimo deal & capital allocation: Commentators flagged near‑term uncertainty around integration, capital allocation and how incremental spending/financing (including the euro notes) will affect returns, adding to investor caution. Read More.
• Negative Sentiment: Insider selling & repositioning by institutions: Reports of recent insider sales and large institutional rebalancing were cited in market coverage, which may have amplified downward pressure. Read More.

Analyst Ratings Changes

A number of research firms have recently weighed in on DHR. JPMorgan Chase & Co. dropped their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research report on Wednesday. Guggenheim decreased their price target on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday. Robert W. Baird lowered their price objective on Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research report on Friday, April 17th. Barclays cut their target price on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Finally, TD Cowen reduced their target price on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $242.45.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.